In 2010, Cordier and collaborators assessed the feasibility of radiotherapy with local injections of 213Bi-DOTA-substance P in five patients with critically located gliomas (two glioblastomas, one WHO-grade-III glioma, two WHO-grade-II gliomas). The gene discussed is TAC1; the disease is glioblastoma.